Discounted Cash Flow (DCF) Analysis Unlevered

Cocrystal Pharma Inc (COCP)

$ 1.17
-0.02 (-1.68%)

Operating Data

Year
A/P
2013
Projected
2014
Projected
2015
Projected
2016
Projected
2017
Projected
2018
Projected
2019
Projected
2020
Projected
2021
Projected
2022
Projected
2023
Projected
2024
Projected
2025
Projected
Revenue -------------
Revenue (%)
EBITDA -------------
EBITDA (%)
EBIT -------------
EBIT (%)
Depreciation -------------
Depreciation (%)

Balance Sheet Data

Year
A/P
2013
Actual
2014
Actual
2015
Actual
2016
Actual
2017
Actual
2018
Actual
2019
Actual
2020
Actual
2021
Projected
2022
Projected
2023
Projected
2024
Projected
2025
Projected
Total Cash -------------
Total Cash (%)
Account Receivables -------------
Account Receivables (%)
Inventories -------------
Inventories (%)
Accounts Payable -------------
Accounts Payable (%)
Capital Expenditure -------------
Capital Expenditure (%)

Weighted Average Cost Of Capital

Share price $ 1.17
Beta 0.744
Diluted Shares Outstanding 31.86
Cost of Debt
Tax Rate 0.00
After-tax Cost of Debt 5.00%
Risk-Free Rate
Market Risk Premium
Cost of Equity 8.381
Total Debt 0.60
Total Equity 37.28
Total Capital 37.87
Debt Weighting 1.57
Equity Weighting 98.43
Wacc

Build Up Free Cash

Year
A/P
2013
Projected
2014
Projected
2015
Projected
2016
Projected
2017
Projected
2018
Projected
2019
Projected
2020
Projected
2021
Projected
2022
Projected
2023
Projected
2024
Projected
2025
Projected
Revenue -------------
EBITDA -------------
EBIT -------------
Tax Rate -68.57%34.44%23.33%28.19%91.82%21.69%0.00%0.00%16.36%16.36%16.36%16.36%16.36%
EBIAT -------------
Depreciation -------------
Accounts Receivable -------------
Inventories -------------
Accounts Payable -------------
Capital Expenditure --0.01-0.34-0.05-0.04-0.03-0.14-0.24-----
UFCF -------------
WACC
PV UFCF -------------
SUM PV UFCF -

Terminal Value

Growth in perpetuity method:
Long-term growth rate
WACC (%) 8.33
Free cash flow (t + 1) -
Terminal Value -
Present Value of Terminal Value -

Intrinsic Value

Enterprise Value -
Net Debt -32.41
Equity Value -
Shares Outstanding 31.86
Equity Value Per Share -